The abstract is read at the publisher; the summary is JClub's.
In a specialist IBS clinic in Leeds, UK, Rome V criteria for IBS showed 66·1% sensitivity and 80·1% specificity, with a positive likelihood ratio of 3·33.
- Why it matters: Rome V criteria were proposed in May, 2026, but their diagnostic performance in routine clinical practice was unknown, creating uncertainty about how well they identify IBS patients.
- What they did: Consecutive adults aged 16+ referred with suspected IBS (Sept 22, 2016–June 18, 2024) had standardized investigations and masked assessment; performance of Rome V was compared with Rome III and Rome IV using a reference standard based on symptoms plus no organic disease.
- The result: Among 590 reference-standard IBS cases, 390 met Rome V criteria; Rome V had sensitivity 66·1% and specificity 80·1%, identifying a different patient group with lower sensitivity than Rome III or Rome IV in this single-centre study.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.